WallStreetZenWallStreetZen

NASDAQ: CVKD
Cadrenal Therapeutics Inc Stock Ownership - Who owns Cadrenal Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cadrenal Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matthew K. SzotChief Financial Officer2025-12-299,933$6.97
$69.23kSell
Matthew K. SzotChief Financial Officer2025-10-271,800$13.99
$25.18kSell
Quang X. PhamCEO and Chairman2025-10-271,315$13.99
$18.40kSell
Quang X. PhamCEO and Chairman2025-10-241,129$14.03
$15.84kSell
Matthew K. SzotChief Financial Officer2025-10-241,800$13.99
$25.18kSell
Matthew K. SzotChief Financial Officer2025-10-131,800$14.07
$25.33kSell
Quang X. PhamCEO and Chairman2025-10-131,800$14.15
$25.47kSell
Matthew K. SzotChief Financial Officer2025-10-091,693$13.99
$23.69kSell
Quang X. PhamCEO and Chairman2025-10-091,800$14.02
$25.24kSell
Matthew K. SzotChief Financial Officer2025-10-06107$13.99
$1.50kSell

1 of 3

CVKD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CVKD insiders and whales buy or sell their stock.

CVKD Shareholders

What type of owners hold Cadrenal Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
John Raymond Murphy29.62%614,792$4.59MInsider
Quang X. Pham19.08%396,089$2.95MInsider
Vanguard Group Inc2.61%54,239$404.62kInstitution
Glynn Wilson2.41%50,000$373.00kInsider
Steven Zelenkofske1.93%40,000$298.40kInsider
Citadel Advisors LLC0.96%19,864$148.19kInstitution
Lpl Financial LLC0.68%14,200$105.93kInstitution
Geode Capital Management LLC0.61%12,710$94.82kInstitution
Jpmorgan Chase Co0.36%7,500$55.95kInstitution
Blackrock Inc0.16%3,378$25.20kInstitution

1 of 3

CVKD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CVKD5.50%53.11%Net SellingNet Selling
APLT65.67%8.65%Net SellingNet Selling
LIMN0.97%85.86%
OSRH0.60%99.40%
KAPA2.14%36.51%
View Top Biotech Stocks

Cadrenal Therapeutics Stock Ownership FAQ

Who owns Cadrenal Therapeutics?

Cadrenal Therapeutics (NASDAQ: CVKD) is owned by 5.50% institutional shareholders, 53.11% Cadrenal Therapeutics insiders, and 41.38% retail investors. John Raymond Murphy is the largest individual Cadrenal Therapeutics shareholder, owning 614,792.00 shares representing 29.62% of the company. John Raymond Murphy's Cadrenal Therapeutics shares are currently valued at $4.27M.

If you're new to stock investing, here's how to buy Cadrenal Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.